MHS
ABBV icon

M Holdings Securities’s AbbVie ABBV Stock Holding History

M Holdings Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,060
Closed -$682K – 197
2023
Q2 		$682K Sell
5,060
-14,652
-74% -$2.15M 0.14% 91
2023
Q1 		$3.14M Buy
+19,712
New +$3.01M 0.32% 57

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

M Holdings Securities's ABBV Position: Q1 2026 in Review

M Holdings Securities reduced its AbbVie (ABBV) stake by 1% in Q1 2026, selling an estimated $52.4K and leaving 22,535 shares worth $4.73M. The position accounts for 0.32% of the portfolio, ranked #57.

M Holdings Securities first reported a position in ABBV in Q4 2013 and has held it in 41 quarters since. The position peaked at $5.2M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • M Holdings Securities held 22,535 shares of AbbVie worth $4.73M as of Q1 2026.
  • M Holdings Securities sold 236 AbbVie shares in Q1 2026, an estimated $52.4K.
  • AbbVie made up 0.32% of M Holdings Securities's portfolio in Q1 2026, its #57 holding.
  • M Holdings Securities first reported a position in AbbVie in Q4 2013 and has held it in 41 quarters since.
  • M Holdings Securities's AbbVie position peaked at $5.2M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on M Holdings Securities's 13F filing for Q1 2026, filed 12 May 2026.